.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Julphar
Colorcon
Cipla
Covington
Farmers Insurance
US Department of Justice
Daiichi Sankyo
Chubb
Harvard Business School

Generated: July 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017573

« Back to Dashboard
NDA 017573 describes VANCERIL, which is a drug marketed by Schering and is included in two NDAs. Additional details are available on the VANCERIL profile page.

The generic ingredient in VANCERIL is beclomethasone dipropionate. There are twenty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the beclomethasone dipropionate profile page.

Summary for NDA: 017573

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:AEROSOL, METERED;INHALATIONStrength0.042MG/INH
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Expired Orange Book Patents for NDA: 017573

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering
VANCERIL
beclomethasone dipropionate
AEROSOL, METERED;INHALATION017573-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Schering
VANCERIL
beclomethasone dipropionate
AEROSOL, METERED;INHALATION017573-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Schering
VANCERIL
beclomethasone dipropionate
AEROSOL, METERED;INHALATION017573-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Covington
Cantor Fitzgerald
Teva
Queensland Health
US Department of Justice
Express Scripts
Novartis
Colorcon
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot